A consultant physician jeopardised a huge clinical trial into a new diabetes drug by making up the results, the GMC heard today. (mon)
Dr Malcolm Wilson should have followed the study protocol ‘to
This content is for members with full access only.
Please upgrade your membership on your account page to access it.
Upgrade your account